X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation
© 2022. The Author(s)..
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the pathogen that causes COVID-19, produces polyproteins 1a and 1ab that contain, respectively, 11 or 16 non-structural proteins (nsp). Nsp5 is the main protease (Mpro) responsible for cleavage at eleven positions along these polyproteins, including at its own N- and C-terminal boundaries, representing essential processing events for viral assembly and maturation. Using C-terminally substituted Mpro chimeras, we have determined X-ray crystallographic structures of Mpro in complex with 10 of its 11 viral cleavage sites, bound at full occupancy intermolecularly in trans, within the active site of either the native enzyme and/or a catalytic mutant (C145A). Capture of both acyl-enzyme intermediate and product-like complex forms of a P2(Leu) substrate in the native active site provides direct comparative characterization of these mechanistic steps as well as further informs the basis for enhanced product release of Mpro's own unique C-terminal P2(Phe) cleavage site to prevent autoinhibition. We characterize the underlying noncovalent interactions governing binding and specificity for this diverse set of substrates, showing remarkable plasticity for subsites beyond the anchoring P1(Gln)-P2(Leu/Val/Phe), representing together a near complete analysis of a multiprocessing viral protease. Collectively, these crystallographic snapshots provide valuable mechanistic and structural insights for antiviral therapeutic development.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Nature communications - 13(2022), 1 vom: 03. Sept., Seite 5196 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lee, Jaeyong [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 08.09.2022 Date Revised 26.09.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41467-022-32854-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM34574859X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM34574859X | ||
003 | DE-627 | ||
005 | 20231226025759.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41467-022-32854-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n1152.xml |
035 | |a (DE-627)NLM34574859X | ||
035 | |a (NLM)36057636 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lee, Jaeyong |e verfasserin |4 aut | |
245 | 1 | 0 | |a X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.09.2022 | ||
500 | |a Date Revised 26.09.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s). | ||
520 | |a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the pathogen that causes COVID-19, produces polyproteins 1a and 1ab that contain, respectively, 11 or 16 non-structural proteins (nsp). Nsp5 is the main protease (Mpro) responsible for cleavage at eleven positions along these polyproteins, including at its own N- and C-terminal boundaries, representing essential processing events for viral assembly and maturation. Using C-terminally substituted Mpro chimeras, we have determined X-ray crystallographic structures of Mpro in complex with 10 of its 11 viral cleavage sites, bound at full occupancy intermolecularly in trans, within the active site of either the native enzyme and/or a catalytic mutant (C145A). Capture of both acyl-enzyme intermediate and product-like complex forms of a P2(Leu) substrate in the native active site provides direct comparative characterization of these mechanistic steps as well as further informs the basis for enhanced product release of Mpro's own unique C-terminal P2(Phe) cleavage site to prevent autoinhibition. We characterize the underlying noncovalent interactions governing binding and specificity for this diverse set of substrates, showing remarkable plasticity for subsites beyond the anchoring P1(Gln)-P2(Leu/Val/Phe), representing together a near complete analysis of a multiprocessing viral protease. Collectively, these crystallographic snapshots provide valuable mechanistic and structural insights for antiviral therapeutic development | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
650 | 7 | |a Polyproteins |2 NLM | |
650 | 7 | |a Viral Proteins |2 NLM | |
650 | 7 | |a Peptide Hydrolases |2 NLM | |
650 | 7 | |a EC 3.4.- |2 NLM | |
650 | 7 | |a 3C-like proteinase, SARS-CoV-2 |2 NLM | |
650 | 7 | |a EC 3.4.22.- |2 NLM | |
650 | 7 | |a Cysteine Endopeptidases |2 NLM | |
650 | 7 | |a EC 3.4.22.- |2 NLM | |
650 | 7 | |a Coronavirus 3C Proteases |2 NLM | |
650 | 7 | |a EC 3.4.22.28 |2 NLM | |
700 | 1 | |a Kenward, Calem |e verfasserin |4 aut | |
700 | 1 | |a Worrall, Liam J |e verfasserin |4 aut | |
700 | 1 | |a Vuckovic, Marija |e verfasserin |4 aut | |
700 | 1 | |a Gentile, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Ton, Anh-Tien |e verfasserin |4 aut | |
700 | 1 | |a Ng, Myles |e verfasserin |4 aut | |
700 | 1 | |a Cherkasov, Artem |e verfasserin |4 aut | |
700 | 1 | |a Strynadka, Natalie C J |e verfasserin |4 aut | |
700 | 1 | |a Paetzel, Mark |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 13(2022), 1 vom: 03. Sept., Seite 5196 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2022 |g number:1 |g day:03 |g month:09 |g pages:5196 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-022-32854-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2022 |e 1 |b 03 |c 09 |h 5196 |